We recently published a list of 10 Best Long Term Growth Stocks to Buy According to Billionaires. In this article, we are ...

Stock analysts at HC Wainwright boosted their Q3 2025 earnings per share (EPS) estimates for shares of Alnylam ...

Alnylam Pharmaceuticals, Inc.’s ALNY share price has dipped by 10.08%, which has investors questioning if this is right time ...

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its target price increased by Stifel Nicolaus from $300.00 to ...

As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, ...

Dr. Sepp-Lorenzino brings to AskBio over 30 years of executive, academic, and Board experienceOther Board positions include ...

RBC Capital analyst Luca Issi maintained a Buy rating on Alnylam Pharma (ALNY – Research Report) on April 3 and set a price target of $330.00.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

William Blair analyst Myles Minter maintained a Buy rating on Argenx Se (ARGX – Research Report) today. The company’s shares closed yesterday ...

Sanofi's Qfitlia gains FDA approval, offering fewer injections in hemophilia care. Check out my recommendation for SNY stock.

Moderna (NasdaqGS:MRNA) recently experienced a 17% decline in share price over the past week, a significant downturn that occurs amidst market-wide turbulence triggered by escalating global trade ...